We make it our goal to bring to you the absolute best of what nature’s medicine has to offer. Every formula is thoughtfully crafted with each botanical being picked for its cannabimimetic properties and proven therapeutic uses throughout time. Cannabimimetic compounds are compounds that act like cannabinoids by binding to your CB1 and CB2 receptors. Flavonoids, terpenes, and select fatty acid profiles are what we search for in each ingredient. Plants like aloe, arnica, hops, helichrysum, and calendula all have incredible anti- inflammatory properties that we infuse into blends of oil that are high in omega-3. We then strengthen those cannabimimetic blends with CBD to create powerful formulas that have a wide span of ailments they help aid your body in recovering from.
Cindy Abrams is a registered nurse with over 49 years’ experience, with progressive leadership positions in operations, business development, clinical research, as well as clinical nursing. While an undergraduate working as a Research Assistant at the University of Arizona, she designed and implemented the Pilot study for Colon Cancer Prevention which launched colon cancer research that is still in progress today. In collaboration with the College of Nursing, she assisted with the development of predictive tools in relationship to compliance with dietary and other healthy habit changes. The Health Locus of Control tool developed for that study in 1994 is still utilized in dietary compliance studies today. She has also served as a clinical leader in the development of a successful hospice, as well as a physician’s group.
Dr. John Streicher earned his Ph.D. from UCLA in 2009, in the lab of Dr. Yibin Wang, where he studied the signal transduction cascades linking heart stress to heart failure. He then went on to a postdoctoral fellowship with Dr. Laura Bohn at Scripps-Florida, where he studied biased signaling at the opioid receptors. In 2012, he joined the faculty at the University of New England, where he combined the threads of his training into a research program focused on the signal transduction cascades of the opioid, cannabinoid, and other brain-relevant receptors, mostly in the context of pain. He joined the faculty of the University of Arizona in 2015, where he continues his work today. Recently, his research program has focused on the effects of terpene compounds found in Cannabis sativa. In a recent paper published in Scientific Reports, his lab found that alpha-humulene, beta-pinene, linalool, and geraniol produced cannabinoid-like effects in mice. This work recently secured funding from the National Institutes of Health to investigate terpenes as potential non-opioid, non-cannabinoid treatments for chronic pain with reduced side effects.
Rhonda Herrera-Blau graduated from the University of Arizona with a degree in Business Administration. For over a decade, she has successfully launched, owned, and operated Assisted Living Homes, overseeing the health and wellbeing of countless individuals. She lost a child to cancer 12 years ago and started looking for alternative therapies to traditional cancer treatment such as chemotherapy. Because of her passion in helping others, she co-created a CBD business, Divine Elements, hoping to spread the awareness of Cannabis therapeutics as a medicinal option for the elderly who are traditionally prescribed opioids. She continues her work today as a patient advocate improving the quality of life for the elderly and others who are seeking alternative forms of medicine.
